Diane M. Thiboutot, M.D.Professor of Dermatology Vice-Chair for Research for Dermatology Director of Clinical & Transitional Science Research Education
Penn State Hershey Dermatology
500 University Drive, UPC 1, Suite 100
Hershey, PA 17033
Tel: 800-243-1455 / 717-531-6820 / (717) 531-6820 Fax: 717-531-4702
Patient Services Provided
Acne Botox injections Juvederm
Residency, Dermatology, Penn State Milton S. Hershey Medical Center (1992) M.D., Penn State Hershey College of Medicine (1988)
Acne Vulgaris- We are continuously conducting mild,moderate and/or severe acne vularis studies to enhance the treatment options for teens and adults who suffer from acne. The studies have involved several combinations of investigational and/or FDA approved topical and/or oral medication.
Rosacea - Our clinical trials office has fully executed research studies applying topical and oral medications both Investigational and FDA approved products. Since there is no cure, there is a necessity to continue research.
Lumsden KR, Nelson AM, Dispenza MC, Gilliland KL, Cong Z, Zaenglein AL, Thiboutot DM
Isotretinoin increases skin-surface levels of neutrophil gelatinase-associated lipocalin in patients treated for sever acne.
Br J Dermatol. 2011 Aug;165(2):302-10 Nelson AM, Cong Z, Gilliland KL, Thiboutot DM
TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells
Br J Dermatol. May12 Thiboutot DM
Rethinking treatment of acne in the severe patient Thiboutot DM
Dermatologists Do Not Yet Fully Understand the Clinical Significance of Antibiotic Use and Bacterial Resistance in Patients With Acne: Comment on
Arch Dermatol. 2011 UG;147(8):921-2 Thiboutot Dm
Introduction. Challenges in managing acne patients.
J Drugs Dermatol. 2011 JUn1;10(6):s7 Show all publications »